For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Synthekine, Inc.

USPTO Granted Patents = 18

Trademarks = 2

Forward Citations = 8

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Patrick J Lupardus (15 out of 15 patents)

Deepti Rokkam (15 out of 18 patents)

Robert Kastelein (14 out of 14 patents)

4. Sandro Vivona (8 out of 8 patents)

5. Martin Oft (3 out of 17 patents)

6. Scott Alan McCauley (3 out of 19 patents)

7. Steve Kauder (3 out of 3 patents)

8. Paul-Joseph Penaflor-Aspuria (2 out of 2 patents)

9. Jan Emmerich (1 out of 1 patent)

10. Mahalakshmi Ramadass (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12448457 - GP130 binding molecules and methods of use (2025-10-21),

2. 12440540 - IL-2 orthologs and methods of use (2025-10-14),

3. 12297281 - IL10RA binding molecules and methods of use (2025-05-13),

4. 12291572 - IL12 receptor synthetic cytokines and methods of use (2025-05-06),

5. 12286482 - IL10RB binding molecules and encoding nucleic acids (2025-04-29),

6. 12234291 - IL2RB binding molecules and methods of use (2025-02-25),

7. 12209132 - Compositions and methods related to IL27 receptor binding (2025-01-28),

8. 12157773 - IL27RAlpha binding molecules and methods of use (2024-12-03),

9. 12139545 - IL10 receptor binding molecules and methods of use (2024-11-12),

10. 12122839 - IFNGR binding synthetic cytokines and methods of use (2024-10-22),

11. 12103954 - Heterodimeric Fc cytokines and uses thereof (2024-10-01),

12. 12077594 - IL2RG binding molecules and methods of use (2024-09-03),

13. 12018085 - Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases (2024-06-25),

14. 12012457 - IL23R binding molecules and methods of use (2024-06-18),

15. 11873349 - Compositions and methods related to IL27 receptor binding (2024-01-16),

Synthekine, Inc. is a biotechnology company focused on developing novel cytokine-based immunotherapies to treat cancer and autoimmune diseases. Their platform technology allows for the precise engineering of cytokines to enhance therapeutic efficacy and reduce side effects. With a strong pipeline of candidates in preclinical development, Synthekine is dedicated to advancing the field of immunotherapy and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#67 in Menlo Park, CA

#4,145 in California

#17,382 in US

#33,147 in the World

Menlo Park, CA, United States of America

Synthekine, Inc.

Forward Citations = 8

10 inventors:

Patrick J Lupardus (15 out of 15 patents)

Deepti Rokkam (15 out of 18 patents)

Robert Kastelein (14 out of 14 patents)

4. Sandro Vivona (8 out of 8 patents)

5. Martin Oft (3 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…